The CD40-CD154 system in anti-infective host defense

被引:81
作者
Grewal, IS
Borrow, P
Pamer, EG
Oldstone, MBA
Flavell, RA
机构
[1] YALE UNIV, SCH MED, IMMUNOBIOL SECT, NEW HAVEN, CT 06520 USA
[2] YALE UNIV, SCH MED, DEPT MED INFECT DIS, NEW HAVEN, CT 06520 USA
[3] YALE UNIV, SCH MED, HOWARD HUGHES MED INST, NEW HAVEN, CT 06520 USA
[4] Scripps Res Inst, DEPT NEUROPHARMACOL, DIV VIROL, LA JOLLA, CA 92037 USA
关键词
D O I
10.1016/S0952-7915(97)80100-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Research in the past few years has documented significant advances in our understanding of the CD40-CD40 ligand (CD154) system in diverse immune functions. This system influences many T cell mediated inflammatory immune responses and effector functions, unmasking a previously unexpected role for CD40-CD154 in cell mediated immunity. Manipulation of CD154 in animal models of infection by the use of CD154-deficient mice or anti-CD154 antibodies has shown the importance of this system in the initiation of the inflammatory response, in the activation of antigen-presenting cells and in resistance to infections.
引用
收藏
页码:491 / 497
页数:7
相关论文
共 50 条
[21]   Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity [J].
Kamanaka, M ;
Yu, P ;
Yasui, T ;
Yoshida, K ;
Kawabe, T ;
Horii, T ;
Kishimoto, T ;
Kikutani, H .
IMMUNITY, 1996, 4 (03) :275-281
[22]   CD40 ON HUMAN ENDOTHELIAL-CELLS - INDUCIBILITY BY CYTOKINES AND FUNCTIONAL REGULATION OF ADHESION MOLECULE EXPRESSION [J].
KARMANN, K ;
HUGHES, CCW ;
SCHECHNER, J ;
FANSLOW, WC ;
POBER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4342-4346
[23]   Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1 [J].
Karmann, K ;
Min, W ;
Fanslow, WC ;
Pober, JS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :173-182
[24]   High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [J].
Koch, F ;
Stanzl, U ;
Jennewein, P ;
Janke, K ;
Heufler, C ;
Kampgen, E ;
Romani, N ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :741-746
[25]  
Lu P, 1996, J IMMUNOL, V156, P3327
[26]  
NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101
[27]   CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4(+) T cell functions [J].
Oxenius, A ;
Campbell, KA ;
Maliszewski, CR ;
Kishimoto, T ;
Kikutani, H ;
Hengartner, H ;
Zinkernagel, RM ;
Bachmann, MF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2209-2218
[28]  
Pamer EG, 1997, HOST RESPONSE INTRAC, P131
[29]  
PEGUETNAVARRO J, 1995, J IMMUNOL, V155, P4241
[30]   ACTIVATED T-CELLS INDUCE EXPRESSION OF B7/BB1 ON NORMAL OR LEUKEMIC B-CELLS THROUGH A CD40-DEPENDENT SIGNAL [J].
RANHEIM, EA ;
KIPPS, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :925-935